¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"NDA : new drug application"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • nonsteroidal antiinflammatory drug
    ºñ½ºÅ×·ÎÀ̵å¼Ò¿°Á¦, ºñ½ºÅ×·ÎÀ̵åÇ׿°ÁõÁ¦
  • orphan drug
    Èñ±Í¾à
  • prescription drug
    󹿾à
  • prokinetic drug
    À§Àå¿îµ¿ÃËÁøÁ¦
  • psychedelic drug
    ȯ°¢Á¦
  • psychoactive drug
    Á¤½ÅÀÛ¿ëÁ¦
  • parasympathomimetic drug
    ºÎ±³°¨½Å°æÈïºÐÁ¦
  • sulfa drug
    ¼úÆÄÁ¦
  • sympathomimetic drug
    ±³°¨½Å°æÈïºÐÁ¦
  • synthetic drug
    ÇÕ¼º¾à
  • vasoactive drug
    Ç÷°üÀÛ¿ë¾à
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • narcotic drug
    ¸¶¾à
  • nonsteroidal antiinflammatory drug
    ºñ½ºÅ×·ÎÀ̵å¼Ò¿°Á¦, ºñ½ºÅ×·ÎÀ̵åÇ׿°ÁõÁ¦
  • orphan drug
    Èñ±ÍÀǾàǰ
  • parasympathetic drug
    ºÎ±³°¨½Å°æ¾à
  • parasympathomimetic drug
    ºÎ±³°¨ÈïºÐÁ¦
  • prokinetic drug
    À§Àå¿îµ¿ÃËÁøÁ¦
  • psychedelic drug
    ȯ°¢Á¦
  • psychoactive drug
    Á¤½ÅÀÛ¿ë¾à
  • sulfa drug
    ¼úÆÄÁ¦
  • sympathomimetic drug
    ±³°¨½Å°æÈïºÐÁ¦
  • synthetic drug
    ÇÕ¼º¾à
  • topical drug
    ±¹¼Ò¾à
  • tranquilizing drug
    Á¤½Å¾ÈÁ¤Á¦, Á¤¿ÂÁ¦
  • tuberculostatic drug
    Ç×°áÇÙÁ¦
  • vasoactive drug
    Ç÷°üÀÛ¿ë¾à
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • drug allergy
    ¾à¹°¾Ë·¯Áö, ¾à¹°(å·Úª) ¾Ë·¹¸£±â.
  • drug allergy
    ¾à¹°¾Ë·¯Áö, ¾à¹°(å·Úª)¾Ë·¹¸£±â.
  • drug delivery system
    ¾à¹°Àü´Þü°è.
  • drug detection
    ¾à¹°°ËÃâ
  • drug disposition tolerance
    ¾à¹°ºÐÇØ³»¼º.
  • drug effect
    ¾à¹°È¿°ú
  • drug eruption
    ¾àÁø(å·òÖ)
  • drug evaluation
    ¾à¹° ¾à¹°Æò°¡(ËâËÑ̰˧).
  • drug exanthem
    ¾àÁø(å·òÖ)
  • drug fever
    ¾à¹°¿­(å·Úªæð).
  • drug habit
    ¸¶¾à±âº®(ئå·ÐîÛþ), ¾à¹°±âº®(å·ÚªÐîÛþ).
  • drug idiosyncrasy
    ¾à¹°Æ¯ÀÌüÁú.
  • drug induced disorder
    ¾à¹°À¯¹ß¼ºÁúȯ
  • drug induced urticaria
    ¾à¹° À¯¹ß µÎµå·¯±â
  • drug industry
    ¾à¹° Á¦¾à°ø¾÷(Ì¡ËâË­Ëâ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
nn nerves; new name [Lat. nomen novum]
NND neonatal death; New and Nonofficial Drugs; nonspecific nonerosive duodenitis
NNO no new orders
n nov new name [Lat. nomen novum]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 7
APD antipsychotic drug
CAD cationic amphiphilic drug
CDER Center for Drug Evaluation and Research
CIDR Controlled Internal Drug Release
DARP Drug Abuse Reporting Program
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hydrophilic drug
    Ä£¼ö¼º ¾àÁ¦
  • immunosuppressive drug
    ¸é¿ª ¾ïÁ¦Á¦
    »ýüÀÇ ¸é¿ª ¹ÝÀÀÀ» ¾ïÁ¦ÇÏ´Â ¾àÁ¦. »ýü ³»¿¡¼­ ¸é¿ª ¹ÝÀÀÀ¸·Î Á¶Á÷ÀÌ Àå¾Ö¸¦ ¹Þ¾Æ º´ÀÌ ÀϾ´Â °æ¿ì°¡ ÀÖ´Ù. ƯÈ÷, Ç׿ø ¹°ÁúÀÌ ÀÚ±âÀÇ Ã¼¼ººÐÀÏ °æ¿ì¿¡´Â ÀÚ°¡ ¸é¿ª ÁúȯÀ̶ó°í ÇÑ´Ù. ÀÚ°¡ ¸é¿ª Áúȯ¿¡¼­´Â ´ë°³ÀÇ °æ¿ì, Á¦ 1¼±ÅÃÁ¦·Î¼­ ºÎ½Å ÇÇÁú È£¸£¸óÀÌ ¾²À̸ç, À̰Ϳ¡ ÀúÇ×À» ³ªÅ¸³»´Â µî ÇѰ谡 ÀÖÀ» °æ¿ì°¡ ÀÖ´Ù. ÀÌ·¯ÇÑ ¶§ ¸é¿ª ¹ÝÀÀÀ¸·Î ÀÎÇÑ º´Å¿¡ ´ëÇÏ¿©, À̸¦ ¾ïÁ¦Çϰí Ä¡·áÇϱâ À§ÇÏ¿© ¸é¿ª ¾ïÁ¦Á¦°¡ »ç¿ëµÈ´Ù. ¶Ç Àå±â ÀÌ½Ä ¶§ °ÅºÎ ¹ÝÀÀÀ» ¾ïÁ¦Çϱâ À§Çؼ­µµ »ç¿ëµÈ´Ù. ¸é¿ª¾ïÁ¦¿¡´Â ±× ¹ÝÀÀ¸¸À» ¾ïÁ¦Çϴ ƯÀÌÇÑ °Í°ú ±×·¸Áö ¾ÊÀº °ÍÀÌ ÀÖÀ¸¸ç, ÀÌ·ÐÀûÀ¸·Î´Â ƯÀÌÇÑ ÂÊÀÇ ÀÛ¿ëÀÌ ¶Ù¾î³ª¾ß ÇϰÚÁö¸¸, ÀÓ»óÀûÀ¸·Î ¾²ÀÌ´Â °ÍÀº °ÅÀÇ ºñƯÀÌÀû ¸é¿ª ¾ïÁ¦Á¦ÀÌ´Ù. ºñƯÀÌÀû ¸é¿ª ¾ïÁ¦Á¦¿¡´Â »çÀÌŬ·ÎÆ÷½ºÆÄ¹Ìµå, ´ÏÆ®·Î°Õ¸¶½ºÅ¸µå µîÀÇ ¾ËųȭÁ¦, 6-¸Þ¸£Ä°ÅäǪ¸°, ¾ÆÀÚÆ¼¿ÀǪ¸°, ½ÃÅä½Å¾Æ¶óºñ³ë½Ãµå µî°ú °°Àº ´ë»ç ±æÇ×Á¦, ¹ÌÅ丶À̽ŠC, ¾ÇƼ³ë¸¶À̽ŠD µîÀÇ Ç×»ý ¹°Áú, ºÎ½Å ÇÇÁú ½ºÅ×·ÎÀ̵åÁ¦, ºó¾ËÄ®·ÎÀ̵åÁ¦, Ç׸²ÇÁ±¸ Ç÷û µîÀÇ Ç×ü µî ¿©·¯ Á¾·ùÀÇ ¾àÁ¦°¡ ÀÖ´Ù. ÀÌµé ¸é¿ª ¾ïÁ¦Á¦´Â Ç׿ø Àڱؿ¡¼­ Ç×ü »ý¼º±îÁö À̸£´Â µ¿¾È¿¡, ¸ÅÅ©·ÎÆÄÁö¿¡ ÀÇÇÑ Ç׿øÀÇ Å½½Ä, ¸²ÇÁ±¸¿¡ ÀÇÇÑ Ç׿ø ÀνÄ, ¼¼Æ÷ ºÐ¿­, T ¼¼Æ÷¿Í B ¼¼Æ÷ÀÇ ºÐ¿­, Ç×ü »ý¼º µî ¸î °¡Áö °úÁ¤À» ÀúÇØ½ÃÅ´À¸·Î½á ¸é¿ª¾ïÁ¦¸¦ ¾ß±â½ÃŲ´Ù. ´ëºÎºÐÀÌ Ç×Á¾¾ç Ȱ¼ºÀ» °¡Áö°í À־, DNA
  • individual drug
    °³°³ÀÎ ¾à¹°
  • Langmuir expression in drug-antibody binding
    ¾à¹°-Ç×ü °áÇÕ¿¡¼­ÀÇ ¶û¹¿¸£ Ç¥Çö
  • lichenoid drug reaction
    ż±¾ç ¾à¹° ¹ÝÀÀ
  • like drug
    ¸ð¸£ÇÉ À¯»ç ¾à¹°
  • long acting drug
    Áö¼Ó¼º ¾à
  • metabolic drug
    ´ë»ç ¾à¹°
  • misbranded drug
    ºÎÁ¤ Ç¥½Ã ¾àǰ
  • morphine like drug
    ¸ð¸£ÇÉ À¯»ç ¾à¹°
  • multiple drug misuse
    ¿©·¯ ¾à¹°ÀÇ ¿À¿ë
  • multiple drug resistance gene
    º¹ÇÕ ¾àÁ¦ ³»¼º À¯ÀüÀÚ
  • narcotic drug
    ¸¶¾à
    ¸ð¸£ÇÉ, ÄÚÄ«ÀÎ, ¾ÆÆí µî°ú ±× À¯µµÃ¼·Î¼­ ¹Ì·®À¸·Î °­·ÂÇÑ ÁøÅë ÀÛ¿ë°ú ¸¶Ãë ÀÛ¿ëÀ» Áö´Ï¸ç °è¼Ó »ç¿ëÇÏ¸é ½À°ü¼º°ú Ž´Ð¼ºÀÌ »ý±â°Ô ÇÏ´Â ¹°Áú. »ç¿ëÀ» Áß´ÜÇÏ¸é °Ý·ÄÇÑ ±Ý´Ü Áõ¼¼¸¦ ÀÏÀ¸ÄÑ ¸¶¾àÀ» »ç¿ëÇÏÁö ¾Ê°í´Â Á¤»óÀûÀÎ »ýȰÀ» ÇÒ ¼ö ¾ø°Ô µÇ¸ç, Á¾±¹¿¡ °¡¼­´Â À°Ã¼ÀûÀ¸·Î³ª Á¤½ÅÀûÀ¸·Î ÆóÀÎÀÌ µÇ°Ô ÇÏ´Â ¹°ÁúÀÌ´Ù. ÀÌ·± ¹°ÁúÀÌ ÀÇ·á ¹× ¿¬±¸ ÀÌ¿ÜÀÇ ¸ñÀû¿¡ ³²¿ëµÇ´Â À§ÇèÀ» ¹æÁöÇϱâ À§ÇÏ¿© Á¤ÇÑ ¹ý·ü»ó ¿ë¾î°¡ ¸¶¾àÀÌ´Ù. ¸¶¾àÀº ¨ç ¾Þ¼Ó¿¡¼­ äÃëÇÏ´Â ¾ÆÆí ¾ËÄ®·ÎÀ̵å°è ¸¶¾à
  • negative drug history
    À½¼º Åõ¾à º´·Â
  • neuroleptic drug
    ½Å°æ ÀÌ¿ÏÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 7
drug-induced lupus <dermatology> An inflammatory autoimmune disorder, similar to lupus, that develops in response to the use of a particular medication. It is characterised by anti-histone antibodies. More benign than the usual disease, with less renal involvement. The syndrome clears after stopping the offending drug.
Drugs that are known to cause this reaction include procainamide, isoniazid, sulphasalazine, hydralazine, methyldopa, phenytoin, chlorpromazine and penicillamine.
The arthritis, cardiac, pulmonary and systemic features may be present, but the kidney involvement (nephritis) and neurologic disease are rare.
Symptoms generally resolve spontaneously after stopping the medication. Complications include myocarditis, pericarditis, thrombocytopenic purpura and infections.
(18 Jul 2002)
drug-induced tremor <neurology, pharmacology> A drug-induced condition where there is shaking (tremor) of the extremities that is increased with purposeful movement.
Drugs known to induce tremor include: theophylline, Alupent, cyclosporine, amphetamines, lithium and caffeine.
(27 Sep 1997)
drug industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
(12 Dec 1998)
drug information services Services providing pharmaceutic and therapeutic drug information and consultation.
(12 Dec 1998)
drug interaction <pharmacology> A chemical or physiologic reaction that can occur when two different medications are taken together and the interaction may affect the metabolism, effectiveness or toxicity of the other.
(18 Jul 2002)
drug labelling Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
(12 Dec 1998)
drug monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
(12 Dec 1998)
drug, over-the-counter Drug for which a prescription is not needed.
(12 Dec 1998)
drug packaging Containers, packaging, and packaging materials for drugs and biological products. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the united states, such packaging is controlled under the federal food, drug, and cosmetic act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. drug labeling is also available.
(12 Dec 1998)
drug pathogenesis The production of morbid symptoms by drugs.
(05 Mar 2000)
drug, prescription A drug requiring a prescription, a physician's order. By comparison with an over-the-counter drug.
(12 Dec 1998)
drug psychosis Psychosis following or precipitated by ingestion of a drug, e.g., LSD.
(05 Mar 2000)
drug rash Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions.
(12 Dec 1998)
drug residues Drugs and their metabolites which are found in the edible tissues and milk of animals after their medication with specific drugs. This term can also apply to drugs found in adipose tissue of humans after drug treatment.
(12 Dec 1998)
drug resistance The ability of bacteria and other microorganisms to withstand a drug to which they were once sensitive (and were once stalled or killed outright).
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
  • new order
    »õÁúÀú;½ÅüÁ¦;³ªÄ¡ÀÇ µ¶ÀÏ ¹ÎÁ·À» ÁÖü·Î ÇÏ´Â À¯·´ÀçÆí¼º °èȹ
  • new penny
    (¿µ±¹ÀÇ)½ÅÆä´Ï(1971³â ½Ç½Ã)
  • new poor
    ÃÖ±Ù¿¡ ¿µ¶ôÇÑ »ç¶÷µé;»ç¾çÁ·
  • new product
    ½ÅÁ¦Ç°(»õ·Î¿î°ÍÀ¸·Î ÀÎÁ¤µÈ Á¦Ç° ¶Ç´Â ¼­ºñ½º)
  • new town
    ±³¿Ü ÁÖÅÃÁö
  • new wave
    (À¯Çà,¿¹¼ú,Á¤Ä¡µîÀÇ)»õ¹°°á ¿îµ¿;»õdzÁ¶;»õ°æÇâ
  • new woman
    ½Å¿©¼º(ƯÈ÷ 19¼¼±â ¸»°æ ÀνÀ°ú ½Î¿ì¸ç ÀÚÀ¯¿Í µ¶¸³À» ¿ä±¸ÇÑ ¿©¼º)
  • new year
    Á¤¿ù ÃÊÇÏ·ç;¼³³¯
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 7
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 7
ÅëÇÕ°Ë»ö ¿Ï·á